Evidence map›Paper›PMID 24169501›Full record

ArticleDrug and alcohol dependence2014

Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda.

Glenn-Milo Santos, Nneka I Emenyonu, Francis Bajunirwe, A Rain Mocello, Jeffrey N Martin, Eric Vittinghoff, David R Bangsberg, Judith A Hahn

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02330419 (Better Than Study), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02330419 phase2completednot on this mapstarted 2015, after this paper: background citation

Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among MSM

TypeinterventionalSponsorUniversity of California, San FranciscoRan2015 to 2021Enrolled120ConditionsBinge Drinking, HIVArmsPlacebo, Naltrexone, Medical Management (MM) counseling for alcohol use:, Urinalysis for novel alcohol biochemical markers:, Behavioral survey measurements:
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Glenn-Milo SantosUniversity of California, San Francisco, United States; San Francisco Department of Public Health, United States.
Nneka I EmenyonuUniversity of California, San Francisco, United States.
Francis BajunirweMbarara University of Science and Technology, Uganda.
A Rain MocelloUniversity of California, San Francisco, United States.
Jeffrey N MartinUniversity of California, San Francisco, United States.
Eric VittinghoffUniversity of California, San Francisco, United States.
David R BangsbergMassachusetts General Hospital, United States.
Judith A HahnUniversity of California, San Francisco, United States. Electronic address: Judy.hahn@ucsf.edu.
University of California, San Francisco · USMassachusetts General Hospital · USMbarara University of Science and Technology · UGSan Francisco Department of Public Health · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
West Coast AIDS and Cancer Specimen Resource (ACSR)U01CA066529 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCGRATH, MICHAEL SHANNON · 1994 to 2012
$16.1M
Changes in Alcohol Consumption in HIV Positives in UgandaR01AA018631 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2010 to 2013
$2.0M
Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
Intermittent Naltrexone among Polysubstance UsersR36DA035109 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SANTOS, GLENN-MILO · 2012 to 2013
$111k
NCI NIH HHS U01 CA066529NIAAA NIH HHS K24 AA022586NIAAA NIH HHS R01 AA-018631NIAAA NIH HHS R01 AA018631NIAID NIH HHS P30 AI027763NIDA NIH HHS R36 DA035109NIDA NIH HHS R36 DA-035109ANIMH NIH HHS K24 MH087227NIMH NIH HHS R01 MH-054907NIMH NIH HHS R01 MH054907
6 · The paper itself

Abstract

backgroundThere is limited data on the impact of anti-retroviral treatment (ART) initiation on alcohol consumption. We characterized predictors of abstaining from alcohol among HIV-infected individuals following ART initiation.

methodsWe analyzed data from a prospective cohort of HIV-infected adults in Mbarara, Uganda with quarterly measures of self-reported alcohol consumption, socio-demographics, health status, and blood draws. We used pooled logistic regression to evaluate predictors of becoming abstinent from alcohol for at least 90 days after baseline.

resultsAmong the 502 participants, 108 (21.5%) were current drinkers who consumed alcohol within 90 days of baseline, 206 (41.0%) were former drinkers, and 188 (37.5%) were lifetime abstainers at baseline. Among current drinkers, 67 (62.0%) drank at hazardous levels. 90 of current drinkers (83.3%) abstained from alcohol at least for 90 days over 3.6 median years of follow-up [IQR 2-4.8]; of those 69 (76.7%) remained abstinent for a median duration of follow-up of 3.25 years [1.6-4.5]. Becoming abstinent was independently associated with lower baseline AUDIT score (adjusted odds ratio [AOR] 0.95 [95%CI 0.91-0.99]), baseline physical health score (AOR 0.92 [0.87-0.97]), and decreases in physical health score at follow-up visits (AOR 0.92 [0.88-0.97)). Alcohol abstinence was most likely to start immediately after ART initiation (AORs for 6 month versus 3 month visit: 0.25 [0.10-0.61]; 9 month visit or later versus 3 month visit: 0.04 [0.02-0.09]).

conclusionsWe found that a large majority of drinkers starting ART reported that they became and remained abstinent from alcohol. ART initiation may be an opportune time to implement interventions for alcohol consumption and other health behaviors.

Indexed as

Self ReportAdultAlcohol AbstinenceAlcohol DrinkingAntiretroviral Therapy, Highly ActiveCohort StudiesFemaleFollow-Up StudiesHIV InfectionsHumansMaleProspective StudiesRural PopulationTreatment OutcomeUgandaAfricaAlcoholAlcohol abstinenceAntiretroviral treatmentART-initiationHazardous drinkingHIVUganda

Identifiers

PMID24169501
PMCPMC3885244
OpenAlexW2047770736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.